Evidence map›Paper›PMID 41675372›Full record

ArticleQuantitative biology (Beijing, China)2025

AMHF-TP: Multifunctional therapeutic peptides prediction based on multi-granularity hierarchical features.

Shouheng Tuo, YanLing Zhu, Jiangkun Lin, Jiewei Jiang

Abstract read
In one paragraph

Article in Quantitative biology (Beijing, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shouheng TuoSchool of Computer Science and Technology Xi'an University of Posts and Telecommunications Xi'an China.
YanLing ZhuSchool of Computer Science and Technology Xi'an University of Posts and Telecommunications Xi'an China.
Jiangkun LinSchool of Computer Science and Technology Xi'an University of Posts and Telecommunications Xi'an China.
Jiewei JiangSchool of Electronic Engineering Xi'an University of Posts and Telecommunications Xi'an China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multifunctional therapeutic peptides (MFTP) hold immense potential in diverse therapeutic contexts, yet their prediction and identification remain challenging due to the limitations of traditional methodologies, such as extensive training durations, limited sample sizes, and inadequate generalization capabilities. To address these issues, we present AMHF-TP, an advanced method for MFTP recognition that utilizes attention mechanisms and multi-granularity hierarchical features to enhance performance. The AMHF-TP is composed of four key components: a migration learning module that leverages pretrained models to extract atomic compositional features of MFTP sequences; a convolutional neural network and self-attention module that refine feature extraction from amino acid sequences and their secondary structures; a hypergraph module that constructs a hypergraph for complex similarity representation between MFTP sequences; and a hierarchical feature extraction module that integrates multimodal peptide sequence features. Compared with leading methods, the proposed AMHF-TP demonstrates superior precision, accuracy, and coverage, underscoring its effectiveness and robustness in MFTP recognition. The comparative analysis of separate hierarchical models and the combined model, as well as with five contemporary models, reveals AMHF-TP's exceptional performance and stability in recognition tasks.

Indexed as

deep learninghypergraphmultifunctional therapeutic peptidesmulti‐granularity hierarchical features

Identifiers

PMID41675372
PMCPMC12806036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.